The way to data: opinions and recommendations for the provision of health data for secondary use

Czech version

Authors: Aleš Tichopád ¹; Martin Augustynek ²; Jiří Beneš ³; Martin Dlouhý ⁴; Tomáš Doležal ^5,6; Dana Horáková ⁷; Michal Kršek ⁸; Lenka Lhotská ⁹; Petr Panzner ¹⁰; Marek Penhaker ²; Miroslav Petr ¹¹; Jan Piťha ¹²; Boris Popesko ¹³; Martin Rožánek ¹; Miloš Táborský ¹⁴; Michal Vrablík ⁸
Authors‘ workplace: Katedra biomedicínské techniky FBMI ČVUT v Praze ¹; Katedra kybernetiky a biomedicínského inženýrství FEI VŠB – TU, Ostrava ²; Ústav biofyziky a informatiky 1. LF UK v Praze ³; Katedra ekonometrie FIS VŠE v Praze ⁴; Institut pro zdravotní ekonomiku a technology assessment (iHETA), Praha ⁵; Farmakologický ústav LF MU v Brně ⁶; Neurologická klinika a Centrum klinických neurověd 1. LF UK a VFN v Praze ⁷; 3. interní klinika – klinika endokrinologie a metabolismu 1. LF UK a VFN v Praze ⁸; Katedra přírodovědných oborů FBMI ČVUT v Praze ⁹; Ústav imunologie a alergologie LF UK a FN Plzeň ¹⁰; Katedra medicínského základu v kinantropologii FTVS UK v Praze ¹¹; Laboratoř pro výzkum aterosklerózy, IKEM, Praha ¹²; Ústav podnikové ekonomiky FME UTB ve Zlíně ¹³; I. interní klinika – kardiologická LF UP a FN Olomouc ¹⁴
Published in: Čas. Lék. čes. 2023; 162: 61-66
Category:

Overview

Healthcare data held by state-run organisations is a valuable intangible asset for society. Its use should be a priority for its administrators and the state. A completely paternalistic approach by administrators and the state is undesirable, however much it aims to protect the privacy rights of persons registered in databases. In line with European policies and the global trend, these measures should not outweigh the social benefit that arises from the analysis of these data if the technical possibilities exist to sufficiently protect the privacy rights of individuals. Czech society is having an intense discussion on the topic, but according to the authors, it is insufficiently based on facts and lacks clearly articulated opinions of the expert public. The aim of this article is to fill these gaps.

Data anonymization techniques provide a solution to protect individuals' privacy rights while preserving the scientific value of the data. The risk of identifying individuals in anonymised data sets is scalable and can be minimised depending on the type and content of the data and its use by the specific applicant. Finding the optimal form and scope of deidentified data requires competence and knowledge on the part of both the applicant and the administrator. It is in the interest of the applicant, the administrator, as well as the protected persons in the databases that both parties show willingness and have the ability and expertise to communicate during the application and its processing.

Keywords:

health data – anonymization – de-identification – EHDS – GDPR

Sources

Henson P, David G, Albright K et al. Deriving a practical framework for the evaluation of health apps. Lancet Digit Health 2019; 1: 52–54.
The Finnish act on the secondary use of social and health data. 2019. Dostupné na: https://stm.fi/en/secondary-use-of-health-and-social-data
Safran C, Bloomrosen M, Hammond WE et al. Toward a national framework for the secondary use of health data: an American medical informatics association white paper. J Am Med Inform Assoc 2007; 14: 1–9.
Guidance regarding methods for deidentification of protected health information in accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. Health Information Privacy. The Office for Civil Rights (OCR), 2012. Dostupné na: www.hhs.gov/hipaa/for-professionals/privacy/special-topics/de-identification/index.html
Assessment of the EU Member States’ rules on health data in the light of GDPR. Directorate-General Health and Food Safety of the European Commission, Luxembourg, 2021. Dostupné na: https://health.ec.europa.eu/system/files/2021-02/ms_rules_health-data_en_0.pdf
Skovgaard LL, Wadmann S, Hoeyer K. A review of attitudes towards the reuse of health data among people in the European Union: the primacy of purpose and the common good. Health Policy 2019; 123: 564–571.
Nález ústavního soudu Pl. ÚS 25/21. Ústavní soud ČR, 17. ledna 2023. Dostupné na: www.usoud.cz/fileadmin/user_upload/Tiskova_mluvci/Publikovane_nalezy/2023/Pl._25-21_nalez.17-1-23_-_AN.pdf
Nařízení evropského parlamentu a rady (EU) 2016/679, o ochraně fyzických osob v souvislosti se zpracováním osobních údajů a o volném pohybu těchto údajů a o zrušení směrnice 95/46/ES (obecné nařízení o ochraně osobních údajů). Dostupné na: www.uoou.cz/assets/File.ashx?id_org=200144&id_dokumenty=20112
Zákon č. 110/2019 Sb, o zpracování osobních údajů. Dostupné na: https://aplikace.mvcr.cz/sbirka-zakonu/ViewFile.aspx?type=c&id=38632
Opinion 05/2014 on anonymisation techniques. Papers of the Article 29 Working Party. Article 29 Working Party (Art. 29 WP), 2014. Dostupné na: https://ec.europa.eu/justice/article-29/documentation/opinion-recommendation/files/2014/wp216_en.pdf
A European Strategy for data. Evropská komise. Dostupné na: https://digital-strategy.ec.europa.eu/en/policies/strategy-data
el Emam K. Guide to the de-identification of personal health information. Auerbach Publications, New York, 2013.
Sweeney L. Replacing personally-identifying information in medical records, the Scrub system. Proc AMIA Annu Fall Symp 1996: 333–337.
el Emam K, Jonker E, Arbuckle L et al. A systematic review of re-identification attacks on health data. PLoS One 2011; 6: e28071.
el Emam K, Dankar FK, Issa R et al. A globally optimal k-anonymity method for the de-identification of health data. J Am Med Inform Ass 2009; 16: 670–682.
Kayaalp M. Modes of de-identification. AMIA Annu Symp Proc 2018; 2017: 1044–1050.
Kayaalp M. Patient privacy in the era of big data. Balkan Med J 2018; 35: 8–17.

Labels

Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management

ÚVODEM

EDITORIAL

Seasonal and weekly fluctuations in alcohol use in the Czech Republic

Health aspects of the behaviour of the Czech population during the COVID-19 pandemic from a public health perspective

The dementia-friendly community and its implications for healthcare

Physicians’ experiences of intercultural differences in communication with Ukrainian refugees during the Russian-Ukrainian armed conflict

Changes in the level of health literacy in Czechia between 2015 and 2020

Making the hospital care in the Czech Republic more effective through volunteering

Health systems in the mirror of international comparisons

Minnesota Tobacco Withdrawal Scale revision 2020, validated Czech translation

The role of interleukin 6 in the pathogenesis and therapy of Castleman disease – an immunologist's perspective

Hepatocellular carcinoma, multiple primary neoplasia, and their association with diabetes type 2